Zuo Wei, Zhang Shuai, Xia Cong-Yuan, Guo Xiao-Feng, He Wen-Bin, Chen Nai-Hong
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Department of Pharmacology, Institute of Materia Medica, and Neuroscience Center, Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Shanxi University of Traditional Chinese Medicine, Taiyuan 030024, China.
Neuropharmacology. 2014 Nov;86:103-15. doi: 10.1016/j.neuropharm.2014.07.002. Epub 2014 Jul 10.
Mitochondria dysfunction is implicated in diverse conditions, including metabolic and neurodegenerative disorders. Mitochondrial dynamics has attracted increasing attention as to its relationship with mitochondria autophagy, also known as mitophagy, which is critical for degradation of dysfunctional mitochondria maintaining mitochondrial homeostasis. Mitochondrial fission and its role in clearance of injured mitochondria in acute ischemic injury, however, have not been elucidated yet. Here we showed that hypoxic/ischemic conditions led to fragmentation of mitochondria and induction of mitophagy in permanent middle cerebral artery occlusion (pMCAO) rats and oxygen-glucose deprivation (OGD) PC12 cells. Inhibition of Drp1 by pharmacologic inhibitor or siRNA resulted in accumulation of damaged mitochondria mainly through selectively blocking mitophagy without affecting mitochondrial biogenesis and non-selective autophagy. Drp1 inhibitors increased the infarct volume and aggravated the neurological deficits in a rat model of pMCAO. We demonstrated that the devastating role of disturbed mitochondrial fission by inhibiting Drp1 contributed to the damaged mitochondria-mediated injury such as ROS generation, cyt-c release and activation of caspase-3. Taken together, we proved that under hypoxic/ischemic stress a Drp1-dependent mitophagy was triggered which was involved in the removal of damaged mitochondria and cellular survival at the early stage of hypoxic/ischemic injury. Thus, Drp1 related pathway involved in selective removal of dysfunctional mitochondria is proposed as an efficient target for treatment of cerebral ischemia.
线粒体功能障碍与多种疾病有关,包括代谢紊乱和神经退行性疾病。线粒体动力学因其与线粒体自噬(也称为线粒体吞噬)的关系而受到越来越多的关注,线粒体自噬对于功能失调的线粒体的降解以维持线粒体稳态至关重要。然而,线粒体分裂及其在急性缺血性损伤中清除受损线粒体的作用尚未阐明。在这里,我们表明缺氧/缺血条件导致永久性大脑中动脉闭塞(pMCAO)大鼠和氧-葡萄糖剥夺(OGD)PC12细胞中的线粒体碎片化和线粒体自噬的诱导。用药物抑制剂或小干扰RNA(siRNA)抑制动力相关蛋白1(Drp1)主要通过选择性阻断线粒体自噬导致受损线粒体的积累,而不影响线粒体生物合成和非选择性自噬。Drp1抑制剂增加了pMCAO大鼠模型的梗死体积并加重了神经功能缺损。我们证明,通过抑制Drp1扰乱线粒体分裂的破坏性作用导致了受损线粒体介导的损伤,如活性氧(ROS)生成、细胞色素c(cyt-c)释放和半胱天冬酶-3(caspase-3)激活。综上所述,我们证明在缺氧/缺血应激下,触发了一种依赖Drp1的线粒体自噬,其参与了缺氧/缺血损伤早期受损线粒体的清除和细胞存活。因此,参与选择性清除功能失调线粒体的Drp1相关途径被认为是治疗脑缺血的有效靶点。